Acne Drugs: Global Markets

Table of Contents

Chapter 1 Introduction

Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

Overview of Acne Drugs

• Comedonal
• Papulopustular
• Nodulocystic

History of Outbreaks
Regulatory Scenario

• Regulations in the U.S.

Chapter 4 Economic Impact of COVID-19

Impact of COVID-19 on the Global Economy
Government Expenditures on COVID-19
Impact of COVID-19 on Pharma Supply Chains
Disruption of Clinical Trials
Impact on Insurance Providers
Impact on Health Technology Assement
Threat to Healthcare Acquisitions

Chapter 5 Market Dynamics

Market Drivers

• Overview
• Increasing Prevalence of Acne and Facial Skin Diseases
• Unhealthy Eating Habits and Lifestyles Worldwide
• Rise in Adoption of Skin Care Products
• Growing Acne Cases in Geriatric Population

Market Restraints

• Side Effects Associated with Medication
• Presence of Alternatives for Acne Treatment

Market Opportunities

• Unmet Needs in Low- and Middle-Income Countries
• Macroeconomic Indicators

Chapter 6 Market Factor Analysis

Porter's Five Forces Model

• Bargaining Power of Suppliers
• Bargaining Power of Buyers
• Threat of New Entrants
• Threat of Substitutes
• Intensity of Rivalry

Value Chain Analysis

• R&D
• Clinical Testing
• Manufacturing
• Marketing and Sales
• Post-Sales Services

Chapter 7 Market Breakdown by Drug Type

Global Market for Acne Drugs by Drug Type
Retinoid

• Market Size and Forecast

Antibiotics

• Market Size and Forecast

Hormonal Agents

• Market Size and Forecast

Others

• Market Size and Forecast

Chapter 8 Market Breakdown by Route of Administration

Global Market for Acne Drugs by Route of Administration
Topical

• Market Size and Forecast

Oral

• Market Size and Forecast

Chapter 9 Market Breakdown by Distribution Channel

Global Market for Acne Drugs by Distribution Channel
Over-the-Counter

• Market Size and Forecast

Prescription Based

• Market Size and Forecast

Chapter 10 Market Breakdown by Region

Global Market for Acne Drugs by Region
North and South America

• United States
• Canada

Europe

• Germany
• U.K.
• France
• Italy
• Spain
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• Australia
• South Korea
• Rest of Asia-Pacific

Middle East and Africa

• Market Size and Forecast

Chapter 11 Competitive Landscape

Global Company Ranking
Global Acne Drug Market Insights

Chapter 12 Company Profiles

ALLERGAN
BAUSCH HEALTH COMPANIES INC.
F. HOFFMANN-LA ROCHE LTD.
GALDERMA
GLAXOSMITHKLINE PLC
MYLAN N.V.
PFIZER INC.
PERRIGO
TEVA PHARMACEUTICAL INDUSTRIES LTD.

List of Tables

Summary Table A : Global Market for Acne Drugs, by Drug Type, Through 2025
Summary Table B : Global Market for Acne Drugs, by Route of Administration, Through 2025
Table 1 : Drugs Generally Prescribed for Acne Patients
Table 2 : Acne Drug Categories
Table 3 : Interim Economic Outlook Forecasts, by Country/Region, March 2, 2021
Table 4 : Expenditures on COVID-19 Crisis
Table 5 : Disruptions of Clinical Trials Due to COVID-19, by Therapeutic Area
Table 6 : Global Market for Acne Drugs, by Drug Type, Through 2025
Table 7 : Different Types of Retinoids and their Effects
Table 8 : Global Market for Retinoid for Acne, by Region, Through 2025
Table 9 : Global Market for Antibiotics for Acne, by Region, Through 2025
Table 10 : Global Market for Hormonal Agents for Acne, by Region, Through 2025
Table 11 : Global Market for Other Drugs for Acne, by Region, Through 2025
Table 12 : Global Market for Acne Drugs, by Route of Administration, Through 2025
Table 13 : Global Market for Acne Drugs for Topical Administration, by Region, Through 2025
Table 14 : Global Market for Acne Drugs for Oral Administration, by Region, Through 2025
Table 15 : Global Market for Acne Drugs, by Distribution Channel, Through 2025
Table 16 : Global Market for Over-the-Counter Acne Drugs, by Region, Through 2025
Table 17 : Global Market for Prescription-Based Acne Drugs, by Region, Through 2025
Table 18 : Global Market for Acne Drugs, by Region, Through 2025
Table 19 : North and South American Market for Acne Drugs, by Drug Type, Through 2025
Table 20 : North American Market for Acne Drugs, by Country, Through 2025
Table 21 : European Market for Acne Drugs, by Drug Type, Through 2025
Table 22 : European Market for Acne Drugs, by Country, Through 2025
Table 23 : Asia-Pacific Market for Acne Drugs, by Drug Type, Through 2025
Table 24 : Asia-Pacific Market for Acne Drugs, by Country, Through 2025
Table 25 : Middle Eastern and African Market for Acne Drugs, by Drug Type, Through 2025
Table 26 : Global Company Ranking Analysis in the Market for Acne Drugs, 2019
Table 27 : Recent Developments in the Market for Acne Drugs
Table 28 : Major Manufacturing Sites of Allergan
Table 29 : Allergan: Financials, 2017-2019
Table 30 : Allergan: Product Portfolio
Table 31 : Allergan: Recent Developments, March 2018-April 2020
Table 32 : Bausch Health Companies Inc.: Financials, 2017-2019
Table 33 : Bausch Health Companies Inc.: Revenue, by Business Segment, 2017-2019
Table 34 : Bausch Health Companies Inc.: Product Portfolio
Table 35 : Bausch Health Companies Inc.: Recent Developments, October 2018-April 2020
Table 36 : F. Hoffmann-La Roche Ltd.: Financials, 2019
Table 37 : F. Hoffmann-La Roche Ltd.: Revenue, by Business Segment, 2016-2018
Table 38 : F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 39 : Galderma: Products Overview
Table 40 : Galderma: Recent Developments, April 2015-April 2020
Table 41 : GlaxoSmithKline PLC: Financials, 2017-2019
Table 42 : GlaxoSmithKline PLC: Products and Services
Table 43 : Mylan N.V.: Financial Performance, 2018 and 2019
Table 44 : Mylan N.V.: Product Portfolio
Table 45 : Pfizer Inc.: Financials, 2017-2019
Table 46 : Pfizer Inc.: Products and Services
Table 47 : Perrigo: Key Products
Table 48 : Perrigo: Financials, 2017-2019
Table 49 : Perrigo: Recent Developments, March 2020
Table 50 : Teva Pharmaceutical Industries Ltd.: Product Portfolio
Table 51 : Teva Pharmaceutical Industries Ltd.: Financials, 2017-2019
Table 52 : Teva Pharmaceutical Industries Ltd.: Recent Developments, August 2015-March 2020

List of Figures

Summary Figure A : Global Market for Acne Drugs, by Drug Type, 2018-2025
Summary Figure B : Global Market Shares of Acne Drugs, by Route of Administration, 2019
Figure 1 : Comparison of GDP Growth, by Country, 2019 and 2020
Figure 2 : Distribution of the Disruption of Clinical Trials Due to COVID-19, by Therapeutic Area
Figure 3 : Acne Vulgaris Patients, by Age Group
Figure 4 : Global Market Shares of Acne Drugs, by Drug Type, 2019
Figure 5 : Global Market for Retinoid Acne Drugs, 2019-2025
Figure 6 : Global Market for Retinoid for Acne, by Region, 2018-2025
Figure 7 : Global Market for Antibiotics for Acne, 2019-2025
Figure 8 : Global Market for Antibiotics for Acne, by Region, 2018-2025
Figure 9 : Global Market for Hormonal Agents for Acne, 2019-2025
Figure 10 : Global Market for Hormonal Agents for Acne, by Region, 2018-2025
Figure 11 : Global Market for Other Drugs for Acne, 2019-2025
Figure 12 : Global Market for Other Drugs for Acne, by Region, 2018-2025
Figure 13 : Global Market Shares of Acne Drugs, by Route of Administration, 2019
Figure 14 : Global Market for Acne Drugs for Topical Administration, 2019-2025
Figure 15 : Global Market for Acne Drugs for Topical Administration, by Region, 2018-2025
Figure 16 : Global Market for Acne Drugs for Oral Administration, 2019-2025
Figure 17 : Global Market for Acne Drugs for Oral Administration, by Region, 2018-2025
Figure 18 : Global Market Shares of Acne Drugs, by Distribution Channel, 2019
Figure 19 : Global Market for Over-the-Counter Acne Drugs, 2019-2025
Figure 20 : Global Market for Over-the-Counter Acne Drugs, by Region, 2018-2025
Figure 21 : Global Market for Prescription-Based Acne Drugs, 2019-2025
Figure 22 : Global Market for Prescription-Based Acne Drugs, by Region, 2018-2025
Figure 23 : Global Market Shares of Acne Drugs, by Region, 2019
Figure 24 : North and South America Market Shares of Acne Drugs, by Drug Type, 2019
Figure 25 : North America Market Shares of Acne Drugs, by Country, 2019
Figure 26 : U.S. Market for Acne Drugs, 2019-2025
Figure 27 : Canadian Market for Acne Drugs, 2019-2025
Figure 28 : European Acne Drug Market Shares, by Drug Type, 2019
Figure 29 : European Market Shares of Acne Drugs, by Country, 2019
Figure 30 : German Market for Acne Drugs, 2019-2025
Figure 31 : U.K. Market for Acne Drugs, 2019-2025
Figure 32 : French Market for Acne Drugs, 2019-2025
Figure 33 : Italian Market for Acne Drugs, 2019-2025
Figure 34 : Spanish Market for Acne Drugs, 2019-2025
Figure 35 : Rest of European Market for Acne Drugs, 2019-2025
Figure 36 : Asia-Pacific Market Shares of Acne Drugs, by Drug Type, 2019
Figure 37 : Asia-Pacific Market Shares of Acne Drugs, by Country, 2019
Figure 38 : Chinese Market for Acne Drugs, 2019-2025
Figure 39 : Indian Market for Acne Drugs, 2019-2025
Figure 40 : Japanese Market for Acne Drugs, 2019-2025
Figure 41 : Australian Market for Acne Drugs, 2019-2025
Figure 42 : South Korean Market for Acne Drugs, 2019-2025
Figure 43 : Rest of Asia-Pacific Market for Acne Drugs, 2019-2025
Figure 44 : Middle Eastern and African Market for Acne Drugs, 2019-2025
Figure 45 : Middle Eastern and African Market Shares of Acne Drugs, by Drug Type, 2019
Figure 46 : Allergan: Revenue Share, by Business Unit, 2019
Figure 47 : Allergan: Revenue Share, by Region, 2019
Figure 48 : Bausch Health Companies Inc.: Revenue Share, by Business Segment, 2019
Figure 49 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Segment, 2019
Figure 50 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Region, 2019
Figure 51 : GlaxoSmithKline PLC: Revenue Share, by Business Segment, 2019
Figure 52 : GlaxoSmithKline PLC: Revenue Share, by Region, 2019
Figure 53 : Mylan N.V.: Revenue Share, by Region, 2019
Figure 54 : Pfizer Inc.: Revenue Share, by Business Segment, 2019
Figure 55 : Pfizer Inc.: Revenue Share, by Region, 2019
Figure 56 : Perrigo: Revenue Share, by Business Segment, 2019
Figure 57 : Teva Pharmaceutical Industries Ltd.: Revenue Share, by Region, 2019

当レポートのプレスリリースは発行されておりません。